Sarcopenic obesity and ADT
▪ Prospective 12-wk study, 25 men with locally advanced or recurrent PCa, LHRH agonists.
Lean mass (%) -1.4
Fat mass (%) 4.3
BMI 0.6
Weight 0.6
0
-2 -1 0 1 2 3 4 5
% change at 12-weeks
Smith et al. J Clin Endocrinol Metab, 91(4):1305–1308, 2006